diacerein has been researched along with Diabetes Mellitus, Type 2 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, A; Huang, L; Li, Y; Luo, M; Lv, D; Shen, J; Xue, Y | 1 |
| El-Sherbiny, M; Helal, MG; Said, E; Salem, HA; Samaha, MM | 1 |
| Chailurkit, L; Jangsiripornpakorn, J; Nimitphong, H; Ongphiphadhanakul, B; Saetung, S; Srisuk, S | 1 |
| Guo, S; Guo, X; Li, Z; Zhang, H; Zhang, X | 1 |
| Carson-Chahhoud, K; Hessami, K; Jalali, M; Jamali, N; Keshavarz, P; Kolahi, AA; Nowrouzi-Sohrabi, P; Rezaei, S; Safiri, S; Sahebkar, A; Shahabi, S; Tabrizi, R | 1 |
| Andrades, ME; Fuchs, SC; Lisboa, HK; Moreira, LB; Piovesan, F; Tres, GS | 1 |
| Camey, S; Fuchs, SC; Koehler-Santos, P; Lisboa, HK; Moreira, LB; Pereira, FDS; Piovesan, F; Tres, GS | 1 |
| Cardoso, CRL; Carlos, FO; Leite, NC; Salles, GF; Viegas, BB; Villela-Nogueira, CA | 1 |
| González-López, R; González-Ortiz, M; Martínez-Abundis, E; Ramos-Zavala, MG; Robles-Cervantes, JA; Santiago-Hernández, NJ | 1 |
| Araújo, TG; Bagarolli, RA; Boechat, LH; Carvalheira, JB; Guadagnini, D; Oliveira, AG; Prada, PO; Rocha, GZ; Saad, MJ; Santos-Silva, JC; Tobar, N; Zollner, RL | 1 |
2 review(s) available for diacerein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis.
Topics: Anthraquinones; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2020 |
Effects of Diacerein Intake on Cardiometabolic Profiles in Type 2 Diabetics: A Systematic Review and Meta-Analysis of Clinical Trials.
Topics: Anthraquinones; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Triglycerides | 2021 |
5 trial(s) available for diacerein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes.
Topics: Anthraquinones; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Retrospective Studies; Treatment Outcome | 2022 |
Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial.
Topics: Aged; Anthraquinones; Cytokines; Diabetes Mellitus, Type 2; Female; Humans; Inflammation Mediators; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Placebos | 2017 |
Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial.
Topics: Aged; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Male; Middle Aged; Treatment Outcome | 2018 |
Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial.
Topics: Adult; Anthraquinones; Diabetes Mellitus, Type 2; Double-Blind Method; Elasticity Imaging Techniques; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Placebos; Treatment Outcome | 2019 |
Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial.
Topics: Adult; Anthraquinones; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Obesity; Overweight; Tumor Necrosis Factor-alpha | 2011 |
3 other study(ies) available for diacerein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Aorta, Thoracic; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Insulin Resistance; Male; Molecular Structure; NF-kappa B; Nitric Oxide Synthase; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Diacerein versus adipoRon as adiponectin modulators in experimentally-induced end-stage type 2 diabetes mellitus in rats.
Topics: Adiponectin; Adipose Tissue; Animals; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Male; Muscle, Skeletal; Piperidines; Rats, Sprague-Dawley | 2022 |
Diacerhein improves glucose tolerance and insulin sensitivity in mice on a high-fat diet.
Topics: Adipose Tissue; Animals; Anthraquinones; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Intolerance; Insulin; Insulin Resistance; Male; Mice; Mice, Obese; Muscle, Skeletal; Obesity | 2011 |